Cumulative antibiotic use significantly decreases efficacy of checkpoint inhibitors in patients with advanced cancer-reply to the editors
Affiliation
The Christie NHS Foundation Trust, ManchesterIssue Date
2020
Metadata
Show full item recordCitation
Tinsley N, Graham DM, Cook N. Cumulative antibiotic use significantly decreases efficacy of checkpoint inhibitors in patients with advanced cancer-reply to the editors. Annals of Translational Medicine. 2020;8.Journal
Annals of Translational MedicineDOI
10.21037/atm.2019.12.06PubMed ID
32175431Additional Links
https://dx.doi.org/10.21037/atm.2019.12.06Type
ArticleLanguage
enae974a485f413a2113503eed53cd6c53
10.21037/atm.2019.12.06
Scopus Count
Collections
Related articles
- Cancer immunotherapy efficacy and patients' sex: a systematic review and meta-analysis.
- Authors: Conforti F, Pala L, Bagnardi V, De Pas T, Martinetti M, Viale G, Gelber RD, Goldhirsch A
- Issue date: 2018 Jun
- Immune checkpoint inhibitors in advanced non-small cell lung cancer.
- Authors: Assi HI, Kamphorst AO, Moukalled NM, Ramalingam SS
- Issue date: 2018 Jan 15
- Breaking the biomarker code: PD-L1 expression and checkpoint inhibition in advanced NSCLC.
- Authors: Melosky B, Chu Q, Juergens RA, Leighl N, Ionescu D, Tsao MS, McLeod D, Hirsh V
- Issue date: 2018 Apr
- Interventional therapy combined with immune checkpoint inhibitors: Emerging opportunities for cancer treatment in the era of immunotherapy.
- Authors: Chang X, Lu X, Guo J, Teng GJ
- Issue date: 2019 Mar
- The Relative Risk and Incidence of Immune Checkpoint Inhibitors Related Pneumonitis in Patients With Advanced Cancer: A Meta-Analysis.
- Authors: Ma K, Lu Y, Jiang S, Tang J, Li X, Zhang Y
- Issue date: 2018